Verfügbarkeit: ESMO clinical recommendations

ESMO clinical recommendations:

Gespeichert in:

Bibliographische Detailangaben
Körperschaft:	European Society for Medical Oncology Guidelines Working Group (VerfasserIn)
Format:	Buch
Sprache:	English
Veröffentlicht:	Oxford Oxford Univ. Press 2007
Schriftenreihe:	Annals of oncology 18, Suppl. 2
Online-Zugang:	Inhaltsverzeichnis
Beschreibung:	94 S.

Internformat

MARC


LEADER	00000nam a2200000 cb4500
001	BV022616104
003	DE-604
005	20080924
007	t
008	070820s2007 \|\|\|\| 00\|\|\| eng d
035			\|a (OCoLC)255857112
035			\|a (DE-599)HBZHT015245514
040			\|a DE-604 \|b ger \|e rakwb
041	0		\|a eng
049			\|a DE-19
110	2		\|a European Society for Medical Oncology \|b Guidelines Working Group \|e Verfasser \|0 (DE-588)6067293-6 \|4 aut
245	1	0	\|a ESMO clinical recommendations \|c guest ed.: ESMO Guidelines Working Group
264		1	\|a Oxford \|b Oxford Univ. Press \|c 2007
300			\|a 94 S.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	0		\|a Annals of oncology \|v 18, Suppl. 2
856	4	2	\|m HBZ Datenaustausch \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015822239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-015822239

Datensatz im Suchindex

_version_	1804136774032687104
adam_text	Volume 18, 2007 Supplement 2 ESMO Clinical Recommendations Towards a convenient way to practice Medical Oncology U3 Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii5 Recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U9 Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up iii2 Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U15 Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U17 Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U19 Colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow up im Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U23 Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii25 Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow up U27 Non small cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U30 Small cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1132 Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U34 Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U36 Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U38 Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U40 Mixed or non seminomatous germ cell tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1142 Multiple myeloma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U44 Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii47 Volume 181 Supplement 2 \| April 2007 Chronic lymphocytic leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1149 Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1151 Hodgkin s disease: ESMO Clinical Recommendations for diagnosis, treatment and follow up U53 Newly diagnosed large B cell non Hodgkin s lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U55 Relapsed large B cell non Hodgkin s lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1157 Gastric marginal zone lymphoma of mucosa associated lymphoid tissue type: ESMO Clinical Recommendations for diagnosis, treatment and follow up U59 Primary cutaneous lymphomas: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii6i Newly diagnosed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii63 Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii65 Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1167 Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U69 Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii7i Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii74 Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U77 Ewing s sarcoma of bone: ESMO Clinical Recommendations for diagnosis, treatment and follow up U79 Cancers of unknown primary site: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii8i Chemotherapy induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis ii83 Erythropoietins in cancer patients: ESMO Recommendations for use ii86 Hematopoietic growth factors: ESMO Recommendations for the application U89 Management of cancer pain: ESMO Clinical Recommendations iiga
adam_txt	Volume 18, 2007 Supplement 2 ESMO Clinical Recommendations Towards a convenient way to practice Medical Oncology U3 Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii5 Recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U9 Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up iii2 Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U15 Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U17 Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U19 Colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow up im Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U23 Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii25 Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow up U27 Non small cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U30 Small cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1132 Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U34 Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U36 Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up U38 Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U40 Mixed or non seminomatous germ cell tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1142 Multiple myeloma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U44 Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii47 Volume 181 Supplement 2 \| April 2007 Chronic lymphocytic leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1149 Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1151 Hodgkin's disease: ESMO Clinical Recommendations for diagnosis, treatment and follow up U53 Newly diagnosed large B cell non Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U55 Relapsed large B cell non Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1157 Gastric marginal zone lymphoma of mucosa associated lymphoid tissue type: ESMO Clinical Recommendations for diagnosis, treatment and follow up U59 Primary cutaneous lymphomas: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii6i Newly diagnosed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii63 Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii65 Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow up 1167 Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U69 Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii7i Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii74 Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow up U77 Ewing's sarcoma of bone: ESMO Clinical Recommendations for diagnosis, treatment and follow up U79 Cancers of unknown primary site: ESMO Clinical Recommendations for diagnosis, treatment and follow up ii8i Chemotherapy induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis ii83 Erythropoietins in cancer patients: ESMO Recommendations for use ii86 Hematopoietic growth factors: ESMO Recommendations for the application U89 Management of cancer pain: ESMO Clinical Recommendations iiga
any_adam_object	1
any_adam_object_boolean	1
author_corporate	European Society for Medical Oncology Guidelines Working Group
author_corporate_role	aut
author_facet	European Society for Medical Oncology Guidelines Working Group
author_sort	European Society for Medical Oncology Guidelines Working Group
building	Verbundindex
bvnumber	BV022616104
ctrlnum	(OCoLC)255857112 (DE-599)HBZHT015245514
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01026nam a2200265 cb4500</leader><controlfield tag="001">BV022616104</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080924 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">070820s2007 \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)255857112</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT015245514</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">European Society for Medical Oncology</subfield><subfield code="b">Guidelines Working Group</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)6067293-6</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">ESMO clinical recommendations</subfield><subfield code="c">guest ed.: ESMO Guidelines Working Group</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">94 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Annals of oncology</subfield><subfield code="v">18, Suppl. 2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015822239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-015822239</subfield></datafield></record></collection>
id	DE-604.BV022616104
illustrated	Not Illustrated
index_date	2024-07-02T18:18:13Z
indexdate	2024-07-09T21:01:44Z
institution	BVB
institution_GND	(DE-588)6067293-6
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-015822239
oclc_num	255857112
open_access_boolean
owner	DE-19 DE-BY-UBM
owner_facet	DE-19 DE-BY-UBM
physical	94 S.
publishDate	2007
publishDateSearch	2007
publishDateSort	2007
publisher	Oxford Univ. Press
record_format	marc
series2	Annals of oncology
spelling	European Society for Medical Oncology Guidelines Working Group Verfasser (DE-588)6067293-6 aut ESMO clinical recommendations guest ed.: ESMO Guidelines Working Group Oxford Oxford Univ. Press 2007 94 S. txt rdacontent n rdamedia nc rdacarrier Annals of oncology 18, Suppl. 2 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015822239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis
spellingShingle	ESMO clinical recommendations
title	ESMO clinical recommendations
title_auth	ESMO clinical recommendations
title_exact_search	ESMO clinical recommendations
title_exact_search_txtP	ESMO clinical recommendations
title_full	ESMO clinical recommendations guest ed.: ESMO Guidelines Working Group
title_fullStr	ESMO clinical recommendations guest ed.: ESMO Guidelines Working Group
title_full_unstemmed	ESMO clinical recommendations guest ed.: ESMO Guidelines Working Group
title_short	ESMO clinical recommendations
title_sort	esmo clinical recommendations
url	http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=015822239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
work_keys_str_mv	AT europeansocietyformedicaloncologyguidelinesworkinggroup esmoclinicalrecommendations

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge